Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spring Kong

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
Journal of the American College of Radiology : JACR|July 30, 2013
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Joe Yujiao Chang, Indrin J Chetty, et al.
American Journal of Clinical Oncology|September 3, 2014
ACR appropriateness Criteria® early-stage non-small-cell lung cancerGregory M M Videtic, Joe Yujiao Chang, Indrin J Chetty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 4, 2018
Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancerFeng-Ming Spring Kong, Ling Li, Weili Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2024
Interpretable deep learning insights: Unveiling the role of 1 Gy volume on lymphopenia after radiotherapy in breast cancerFang Chen, Ping Zhou, Ge Ren, et al.
Oncotarget|January 18, 2018
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA scoreYongmei Liu, Lei Deng, Xiaojuan Zhou, et al.
Translational Oncology|December 9, 2017
Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine LevelsPeter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Radiation dose-volume effects in the lungLawrence B Marks, Soren M Bentzen, Joseph O Deasy, et al.
Annals of Translational Medicine|September 17, 2021
Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapyFang Chen, Hao Yu, Hong Zhang, et al.
Frontiers in Oncology|May 23, 2022
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast CancerFang Chen, Jian-Yue Jin, Timothy S K Hui, et al.
Frontiers in Oncology|May 31, 2021
Individualized Nomogram for Predicting Survival in Patients with Brain Metastases After Stereotactic Radiosurgery Utilizing Driver Gene Mutations and Volumetric SurrogatesCheng Zhou, Changguo Shan, Mingyao Lai, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
Journal of the American College of Radiology : JACR|July 30, 2013
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Joe Yujiao Chang, Indrin J Chetty, et al.
American Journal of Clinical Oncology|September 3, 2014
ACR appropriateness Criteria® early-stage non-small-cell lung cancerGregory M M Videtic, Joe Yujiao Chang, Indrin J Chetty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 4, 2018
Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancerFeng-Ming Spring Kong, Ling Li, Weili Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2024
Interpretable deep learning insights: Unveiling the role of 1 Gy volume on lymphopenia after radiotherapy in breast cancerFang Chen, Ping Zhou, Ge Ren, et al.
Oncotarget|January 18, 2018
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA scoreYongmei Liu, Lei Deng, Xiaojuan Zhou, et al.
Translational Oncology|December 9, 2017
Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine LevelsPeter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Radiation dose-volume effects in the lungLawrence B Marks, Soren M Bentzen, Joseph O Deasy, et al.
Annals of Translational Medicine|September 17, 2021
Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapyFang Chen, Hao Yu, Hong Zhang, et al.
Frontiers in Oncology|May 23, 2022
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast CancerFang Chen, Jian-Yue Jin, Timothy S K Hui, et al.
Frontiers in Oncology|May 31, 2021
Individualized Nomogram for Predicting Survival in Patients with Brain Metastases After Stereotactic Radiosurgery Utilizing Driver Gene Mutations and Volumetric SurrogatesCheng Zhou, Changguo Shan, Mingyao Lai, et al.
Pageof 16